Stock Spotlight — May 23, 2026, 06:00 UTC

Transcript

Welcome back to Stock Spotlight on rawfin.tv! The market is a mixed bag today. The S P 500 is up 0.37 . Our Fear Greed Index sits at 28 indicating Fear. Bitcoin is down 2.64 at 75 392. Today we re spotlighting Medtronic ticker MDT. This healthcare technology giant is a leader in medical devices. They operate globally transforming patient care. Medtronic boasts a substantial market cap nearing 100 billion. Breaking news just hit. Fideuram Intesa Sanpaolo recently acquired a new stake in Medtronic. This institutional vote of confidence is a significant catalyst. It signals strong belief in MDT's long-term value. The bull case for MDT is compelling. Demand for medical devices grows with an aging population. Medtronic s innovation pipeline remains robust. They are expanding into new therapeutic areas. Their global reach offers diversified revenue streams. However risks exist. Regulatory scrutiny in healthcare is ever-present. Intense competition from rivals could impact market share. Supply chain disruptions remain a concern. Economic pressures might delay elective procedures. Looking at the numbers MDT trades around 20 times forward earnings. This is slightly above its sector average. Revenue growth was 4.5 last quarter. Analysts have a consensus price target of 95. This implies a modest upside. Considering both sides Medtronic offers stability and growth potential. The recent institutional backing is encouraging. For now we rate Medtronic a HOLD for existing investors. New money might wait for a better entry point. That s your Stock Spotlight for today. Keep it locked on